FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020851907> ?p ?o ?g. }

• W2020851907 endingPage "1078" @default.
• W2020851907 startingPage "1073" @default.
• W2020851907 abstract "Background and purpose: Recently, we reported that 12(S)-HPETE (12(S)-hydroperoxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid) induces scratching in ICR mice. We hypothesized that 12(S)-HPETE might act as an agonist of the low-affinity leukotriene B4 receptor BLT2. To confirm the involvement of the BLT2 receptor in 12(S)-HPETE-induced scratching, we studied the scratch response using the BLT2 receptor agonists compound A (4′-{[pentanoyl (phenyl) amino]methyl}-1,1′-biphenyl-2-carboxylic acid) and 12(S)-HETE (12(S)-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid). Experimental approach: A video recording was used to determine whether the BLT2 receptor agonists caused itch-associated scratching in ICR mice. Selective antagonists and several chemicals were used. Key results: Both 12(S)-HETE and compound A dose dependently induced scratching in the ICR mice. The dose–response curve for compound A showed peaks at around 0.005–0.015 nmol per site. Compound A- and 12(S)-HETE-induced scratching was suppressed by capsaicin and naltrexon. We examined the suppressive effects of U75302 (6-[6-(3-hydroxy-1E,5Z-undecadienyl)-2-pyridinyl]-1,5-hexanediol, the BLT1 receptor antagonist) and LY255283 (1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]-ethanone, the BLT2 receptor antagonist) on the BLT2 agonist-induced scratching. LY255283 suppressed compound A- and 12(S)-HETE-induced scratching, but U75302 did not. LY255283 required a higher dose to suppress the compound A-induced scratching than it did to suppress the 12(S)-HETE-induced scratching. One of the BLT2 receptor agonists, 12(R)-HETE (12(R)-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid), also induced scratching in the ICR mice. Conclusions and implications: Our present results corroborate the hypothesis that the BLT2 receptor is involved in 12(S)-lipoxygenase-product-induced scratching in ICR mice. We also confirmed that this animal model could be a valuable means of evaluating the effects of BLT2 receptor antagonists. British Journal of Pharmacology (2008) 154, 1073–1078; doi:10.1038/bjp.2008.220; published online 9 June 2008" @default.
• W2020851907 created "2016-06-24" @default.
• W2020851907 creator A5003494351 @default.
• W2020851907 creator A5005050761 @default.
• W2020851907 creator A5008637272 @default.
• W2020851907 creator A5012657662 @default.
• W2020851907 creator A5018847566 @default.
• W2020851907 creator A5020727010 @default.
• W2020851907 creator A5021326810 @default.
• W2020851907 creator A5029879509 @default.
• W2020851907 creator A5041268878 @default.
• W2020851907 creator A5041949892 @default.
• W2020851907 creator A5049060821 @default.
• W2020851907 date "2008-07-01" @default.
• W2020851907 modified "2023-10-06" @default.
• W2020851907 title "Involvement of the BLT₂receptor in the itch-associated scratching induced by 12-(<i>S</i>)-lipoxygenase products in ICR mice" @default.
• W2020851907 cites W1589202049 @default.
• W2020851907 cites W1965700036 @default.
• W2020851907 cites W1966170746 @default.
• W2020851907 cites W1974705948 @default.
• W2020851907 cites W1979941665 @default.
• W2020851907 cites W1983871703 @default.
• W2020851907 cites W1990586473 @default.
• W2020851907 cites W1995733311 @default.
• W2020851907 cites W2000112317 @default.
• W2020851907 cites W2015680388 @default.
• W2020851907 cites W2023154106 @default.
• W2020851907 cites W2024642221 @default.
• W2020851907 cites W2031779809 @default.
• W2020851907 cites W2036550429 @default.
• W2020851907 cites W2039531779 @default.
• W2020851907 cites W2051277347 @default.
• W2020851907 cites W2069874427 @default.
• W2020851907 cites W2073102792 @default.
• W2020851907 cites W2073672889 @default.
• W2020851907 cites W2077436122 @default.
• W2020851907 cites W2085409969 @default.
• W2020851907 cites W2089525532 @default.
• W2020851907 cites W2105176852 @default.
• W2020851907 cites W2116105539 @default.
• W2020851907 cites W2142914135 @default.
• W2020851907 cites W2152244488 @default.
• W2020851907 cites W2171717653 @default.
• W2020851907 cites W4367665840 @default.
• W2020851907 doi "https://doi.org/10.1038/bjp.2008.220" @default.
• W2020851907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2451041" @default.
• W2020851907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18536755" @default.
• W2020851907 hasPublicationYear "2008" @default.
• W2020851907 type Work @default.
• W2020851907 sameAs 2020851907 @default.
• W2020851907 citedByCount "27" @default.
• W2020851907 countsByYear W20208519072012 @default.
• W2020851907 countsByYear W20208519072013 @default.
• W2020851907 countsByYear W20208519072014 @default.
• W2020851907 countsByYear W20208519072015 @default.
• W2020851907 countsByYear W20208519072016 @default.
• W2020851907 countsByYear W20208519072017 @default.
• W2020851907 countsByYear W20208519072019 @default.
• W2020851907 countsByYear W20208519072021 @default.
• W2020851907 countsByYear W20208519072022 @default.
• W2020851907 crossrefType "journal-article" @default.
• W2020851907 hasAuthorship W2020851907A5003494351 @default.
• W2020851907 hasAuthorship W2020851907A5005050761 @default.
• W2020851907 hasAuthorship W2020851907A5008637272 @default.
• W2020851907 hasAuthorship W2020851907A5012657662 @default.
• W2020851907 hasAuthorship W2020851907A5018847566 @default.
• W2020851907 hasAuthorship W2020851907A5020727010 @default.
• W2020851907 hasAuthorship W2020851907A5021326810 @default.
• W2020851907 hasAuthorship W2020851907A5029879509 @default.
• W2020851907 hasAuthorship W2020851907A5041268878 @default.
• W2020851907 hasAuthorship W2020851907A5041949892 @default.
• W2020851907 hasAuthorship W2020851907A5049060821 @default.
• W2020851907 hasBestOaLocation W20208519072 @default.
• W2020851907 hasConcept C121332964 @default.
• W2020851907 hasConcept C170493617 @default.
• W2020851907 hasConcept C185592680 @default.
• W2020851907 hasConcept C24890656 @default.
• W2020851907 hasConcept C2776885963 @default.
• W2020851907 hasConcept C2778122271 @default.
• W2020851907 hasConcept C2778938600 @default.
• W2020851907 hasConcept C2780196728 @default.
• W2020851907 hasConcept C55493867 @default.
• W2020851907 hasConcept C71240020 @default.
• W2020851907 hasConcept C71924100 @default.
• W2020851907 hasConcept C98274493 @default.
• W2020851907 hasConceptScore W2020851907C121332964 @default.
• W2020851907 hasConceptScore W2020851907C170493617 @default.
• W2020851907 hasConceptScore W2020851907C185592680 @default.
• W2020851907 hasConceptScore W2020851907C24890656 @default.
• W2020851907 hasConceptScore W2020851907C2776885963 @default.
• W2020851907 hasConceptScore W2020851907C2778122271 @default.
• W2020851907 hasConceptScore W2020851907C2778938600 @default.
• W2020851907 hasConceptScore W2020851907C2780196728 @default.
• W2020851907 hasConceptScore W2020851907C55493867 @default.
• W2020851907 hasConceptScore W2020851907C71240020 @default.
• W2020851907 hasConceptScore W2020851907C71924100 @default.
• W2020851907 hasConceptScore W2020851907C98274493 @default.
• W2020851907 hasIssue "5" @default.

• next